NRx Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative? have begun treating patients with inhaled ZYESAMI? (Aviptadil), in the I-SPY COVID Trial (NCT04488081), a phase 2 adaptive platform trial aimed at improving treatment for severely ...